Chloroquine enhances replication of Semliki Forest virus and encephalomyocarditis virus in mice.
作者信息
Maheshwari R K, Srikantan V, Bhartiya D
机构信息
Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814-4799.
出版信息
J Virol. 1991 Feb;65(2):992-5. doi: 10.1128/JVI.65.2.992-995.1991.
Abstract
Chloroquine (CHL) has been suggested to play an important role in the development of Burkitt's lymphoma by enhancing Epstein-Barr virus expression. Herpes zoster virus incidence is markedly increased following malaria infection in children being treated with CHL. Recently, CHL has also been shown to dramatically increase the transactivation of Tat protein purified from human immunodeficiency virus. These previous studies indirectly suggest that CHL may be involved in the enhancement of virus replication. This study demonstrates for the first time that CHL indeed enhances Semliki Forest virus and encephalomyocarditis virus replication in mice. These results raise the possible connection between the increased spread of AIDS in endemic malaria areas and the wide use of CHL in those areas for the chemotherapy of malaria.
摘要
相似文献
1
Chloroquine enhances replication of Semliki Forest virus and encephalomyocarditis virus in mice.
J Virol. 1991 Feb;65(2):992-5. doi: 10.1128/JVI.65.2.992-995.1991.
2
Chloroquine enhances viral replication and murine disease.
Am J Trop Med Hyg. 2000 Jan;62(1):1-3. doi: 10.4269/ajtmh.2000.62.1.
3
Tunicamycin enhances virus replication and inhibits antiviral activity of interferon in mice: correlation with natural killer cells.
J Exp Pathol. 1987 Winter;3(1):19-33.
4
Acceleration of viral replication and up-regulation of cytokine levels by antimalarials: implications in malaria-endemic areas.
Am J Trop Med Hyg. 1999 Aug;61(2):180-6. doi: 10.4269/ajtmh.1999.61.180.
5
[Effects of chloroquine on the replication of a murine retrovirus].
Bull Soc Pathol Exot. 1996;89(3):175-8.
6
Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons.
Virology. 1993 Aug;195(2):627-37. doi: 10.1006/viro.1993.1414.
7
Effects of interferon in malaria infection.
Immunol Lett. 1990 Aug;25(1-3):53-7. doi: 10.1016/0165-2478(90)90091-4.
8
Anti-viral activity of single-stranded homopolynucleotides against encephalomyocarditis virus and Semliki Forest virus in adult mice without interferon induction.
J Gen Virol. 1976 Jan;30(1):21-39. doi: 10.1099/0022-1317-30-1-21.
9
Peritoneal barrier to the spread of Semliki forest virus in mice.
Proc Soc Exp Biol Med. 1989 Jan;190(1):70-8. doi: 10.3181/00379727-190-42831.
10
Anti-viral effects of single-stranded polynucleotides against avirulent Semliki Forest virus infection of mice and avirulent infection of rats with encephalomyocarditis virus.
Arch Virol. 1980;64(1):57-66. doi: 10.1007/BF01317391.
引用本文的文献
1
Multiple Factors Involved in Bone Damage Caused by Chikungunya Virus Infection.
Int J Mol Sci. 2023 Aug 23;24(17):13087. doi: 10.3390/ijms241713087.
2
Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment.
J Pharm Sci. 2022 Oct;111(10):2652-2661. doi: 10.1016/j.xphs.2022.06.004. Epub 2022 Jun 9.
3
Regioselective convergent synthesis of 2-arylidene thiazolo[3,2-]pyrimidines as potential anti-chikungunya agents.
RSC Adv. 2020 Jan 31;10(9):5191-5195. doi: 10.1039/d0ra00257g. eCollection 2020 Jan 29.
4
G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19).
Free Radic Res. 2021 Apr;55(4):364-374. doi: 10.1080/10715762.2020.1866757. Epub 2021 Jan 6.
5
Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease.
Medicine (Baltimore). 2020 Dec 24;99(52):e23720. doi: 10.1097/MD.0000000000023720.
6
Chloroquine commonly induces hormetic dose responses.
Sci Total Environ. 2021 Feb 10;755(Pt 1):142436. doi: 10.1016/j.scitotenv.2020.142436. Epub 2020 Sep 25.
7
Small-Molecule Inhibitors of Chikungunya Virus: Mechanisms of Action and Antiviral Drug Resistance.
Antimicrob Agents Chemother. 2020 Nov 17;64(12). doi: 10.1128/AAC.01788-20.
8
Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19.
Pharmacol Ther. 2020 Dec;216:107672. doi: 10.1016/j.pharmthera.2020.107672. Epub 2020 Sep 8.
9
Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy.
Int J Mol Sci. 2020 Jul 14;21(14):4972. doi: 10.3390/ijms21144972.
10
Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.
Travel Med Infect Dis. 2020 May-Jun;35:101735. doi: 10.1016/j.tmaid.2020.101735. Epub 2020 May 6.
本文引用的文献
1
Acquired immunodeficiency syndrome in African patients.
N Engl J Med. 1984 Feb 23;310(8):492-7. doi: 10.1056/NEJM198402233100804.
2
Interferons with special emphasis on the immune system.
Adv Immunol. 1983;34:97-140. doi: 10.1016/s0065-2776(08)60378-8.
3
Effect of chloroquine and some other antimalarials on the immune mechanism in experimental animals.
J Pharm Pharmacol. 1984 Apr;36(4):268-9. doi: 10.1111/j.2042-7158.1984.tb04366.x.
4
Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups.
J Natl Cancer Inst. 1969 Nov;43(5):1147-57.
5
Pre-exposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries.
Am J Trop Med Hyg. 1985 May;34(3):633-47. doi: 10.4269/ajtmh.1985.34.633.
6
Herpes zoster in children following malaria.
J Trop Med Hyg. 1985 Aug;88(4):261-4.
7
8
Evaluation of serological cross-reactivity between antibodies to Plasmodium and HTLV-III/LAV.
Lancet. 1986 Aug 2;2(8501):247-9. doi: 10.1016/s0140-6736(86)92071-4.
9
Cellular uptake of the tat protein from human immunodeficiency virus.
Cell. 1988 Dec 23;55(6):1189-93. doi: 10.1016/0092-8674(88)90263-2.
10
Recent developments in the understanding of the pharmacokinetics and mechanism of action of chloroquine.
Ther Drug Monit. 1989;11(4):369-79.
Zotero 插件